Author

S. R. Viswanathan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:whole-exome sequencing· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Sadagopan· 2 shared G.-S. M. Lee· 2 shared J. Li· 2 shared T. K. Choueiri· 2 shared A. Imamovic· 1 shared A. S. Feldman· 1 shared B. A. McGregor· 1 shared C. Bao· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Sadagopan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinoma

M. Achom, A. Sadagopan, C. Bao, F. McBride, Q. Xu, P. Konda, R. W. Tourdot, J. Li, M. Nakhoul, D. Gallant, U. A. Ahmed, J. O'Toole, D. Freeman, G.-S. M. Lee, J. Hecht, , S. R. Viswanathan

This study identifies a genetic basis for cancer sex differences in Xp11 translocation renal cell carcinoma by showing a 2:1 female:male ratio in TFE3 fusions involving the inactive X chromosome.

bioRxiv · Aug 4, 2023 · PreprintCancer Biology

Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma

Z. Bakouny, A. Sadagopan, P. Ravi, N. Y. Metaferia, J. Li, S. AbuHammad, S. Tang, T. Denize, E. R. Garner, X. Gao, D. A. Braun, L. Hirsch, J. A. Steinharter, G. Bouchard, E. Walton, , S. R. Viswanathan

This study characterizes translocation renal cell carcinoma (tRCC) through integrated clinical and molecular analysis of 152 patients, identifying key features like MiT/TFE fusions, NRF2-driven antioxidant response, and differential treatment outcomes.

bioRxiv · Apr 14, 2021Cancer Biology